“Riproximin Mediated Cytotoxicity and Expression Modifications in Lung Cancer Cells”. Cancer Research and Medicine 1, no. 2 (March 27, 2025): 64–69. Accessed August 8, 2026. https://biologycircle.com/index.php/crm/article/view/25.